Report: Johnson &amp; Johnson in advanced negotiations to buy Guidant
560518
New York (dpa) - Health-care conglomerate Johnson &amp; Johnson is in advanced negotiations to buy defibrillator maker Guidant Corp.
565121
Johnson & Johnson, the pharmaceutical and health care giant, is near a deal to buy Guidant, one of the nation's largest makers of devices to treat heart and circulatory illnesses.
570795
Health care and consumer products maker Johnson & Johnson  on Sunday was close to finalizing details of a &#36;24 billion cash and stock acquisition of medical-device maker Guidant Corp. , according to people familiar with the matter.
282709
Eight months after Boston Scientific Corp. won a bidding war for heart-device maker Guidant Corp. , loser Johnson &amp; Johnson hit it with a $5.5 billion lawsuit that alleges the Natick company improperly induced Guidant to violate the terms of its acquisition deal with Johnson &amp; Johnson.
667986
U.S. stocks were little changed on  Tuesday, with oil prices dropping below $42 a barrel helping to  support markets, but Johnson & Johnson JNJ.N put pressure on  the Dow following a report of a possible $24 billion takeover  of cardiovascular device maker Guidant Corp. GDT.N.
169716
Johnson &amp; Johnson (JNJ:NYSE - news - research) said Wednesday night that it would acquire medical equipment maker Guidant (GDT:NYSE - news - research) for $23.9 billion in cash and stock.
718989
Johnson & Johnson aims to seal a  purchase of Guidant Corp. without immediately jettisoning the  medical device maker's stent operations, sources familiar with  the situation said on Thursday.
335586
After lengthy talks and stiff negotiations over price, the decision by Guidant executives to sell the company for $25.4 billion came down to the attractiveness of Johnson &amp; Johnson&#39;s deep resources.
455781
It has been a long and tortured courtship. For years, health-care giant Johnson &amp; Johnson (JNJ ) has held on-again, off-again acquisition talks with medical-device maker Guidant (GDT ). Now Wall Street sources say the companies are talking again.
546307
Johnson &amp; Johnson (nyse: JNJ - news - people ) is said to be in advanced talks to buy medical device maker Guidant (nyse: GDT - news - people ) for more than $24 billion.
155569
In negotiating to buy Guidant, Johnson & Johnson is looking for an acquisition to increase its presence in the lucrative, fast-growing market for medical devices.
21679
The anticipated merger of Guidant Corp.  and Johnson & Johnson could give an unintended boost to Boston  Scientific Corp. if Guidant's drug-coated stent launch is  delayed, said analysts looking at the implications of a  potential deal.
605466
Johnson &amp; Johnson last night struck a deal to acquire Guidant, the US cardiac treatment group for $25.4bn, in a move that will give it access to one of the fastest growing areas in health care.
420803
Johnson &amp; Johnson has agreed to buy Guidant Corp. for $25.4 billion in cash and stock, the companies said on Wednesday, giving the healthcare products maker a foothold
6925
Johnson &amp; Johnson (JNJ.N: Quote, Profile, Research) on Thursday said it does not see any significant antitrust roadblocks getting in the way of its $25.4 billion acquisition of medical device maker Guidant Corp.
134189
Johnson & Johnson  on Wednesday said it agreed to buy Guidant Corp. , for &#36;25.4 billion in cash and stock, giving the healthcare products maker a foothold in the fast-growing market for implantable devices that regulate heartbeats.
388933
Washington - United States health titan Johnson and Johnson has reached a deal to acquire American heart device manufacturer Guidant, in a stock-and-cash deal valued at $23.9-billion, based on $76 per share, the companies said in a statement early on